InventisBio

Wallstreetcn · Mar 31 at 09:07 PM

Innovative drug concept repeatedly active, ALK straight to the daily limit, Rundu Pharma previously sealed the board, InventisBio, Junshi Biosciences, HWPC, and Biokin Pharmaceutical rose more than 6%

CoinLive · Mar 18 at 04:22 AM

Yifang Biotech's Psoriasis Treatment Receives FDA Phase II Trial Approval

Wallstreetcn · Mar 16 at 09:28 PM

Pharmaceutical stocks fluctuated and surged, with Getein Biotech hitting the daily limit, RemeGen rising nearly 7%, reaching a historical high. Sunshine Guojian Pharmaceutical, EASTON BIOPHARMACEUTICALS, YKYY, Junshi Biosciences, BeBetter Med, and InventisBio also followed suit

Zhitong · Oct 29, 2025 at 04:30 AM

InventisBio: Net loss of 61.8135 million yuan in the third quarter

Zhitong · Sep 9, 2025 at 03:50 AM

Huaxin Securities: A Hundred Flowers Blooming in Biologics and Oral Medications, Promising Future for Psoriasis Treatment

Zhitong · Sep 9, 2025 at 01:19 AM

A-share innovative drug concept stocks fluctuated lower, with InventisBio falling over 10%. Other stocks such as Huahai Pharmaceutical, JENKEM, Lifeon Pharmaceutical, JOINN, Guangsheng Tang, HitGen, and Baillie Gifford also dropped more than 6%